You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -8.1% | 36.4% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -488.2 | 0.0 |
PEG | 0.0 | -0.1 |
Price / Revenue | 50.4 | 0.9 |
Price / Book value | 0.3 |
Latest | Forecast | |
---|---|---|
Revenue | -99.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 13.72 | -2.08 | €-0.06 | -6.2 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 11.47 | -3.43 | -8.00p | -1.6 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 277.20 | 165.17 | 194.00p | 4.4 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 95.78 | -9.83 | -0.14p | -2,614.3 | 0.0 | n/a | n/a | 0.0% |
UK regulator approves Novacyt Covid-19 test Sharecast News | 06 Dec |
---|---|
Novacyt's exsig Covid-19 PCR test receives UK approval Sharecast News | 15 Jul |
Novacyt gets another Covid-19 test approved in the UK Sharecast News | 17 Feb |
Liquidity Agreement and Total Voting Rights | 01-Feb-23 22:55 |
---|---|
DHSC Claim update – Trial date listed | 30-Jan-23 14:19 |
Full Year 2022 Trading Update | 26-Jan-23 14:20 |
Holdings in Company | 06-Jan-23 20:33 |
Liquidity Agreement and Total Voting Rights | 03-Jan-23 21:45 |